XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Instruments
3 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Financial Instruments

NOTE 5 – FINANCIAL INSTRUMENTS

Non-marketable Equity Securities

As of March 31, 2023 and December 31, 2022, other long-term assets included equity securities accounted for under the equity method with a carrying amount of $4.9 million and $4.4 million, respectively. No impairments to the carrying amount of the Company’s non-marketable equity securities were recognized in the three months ended March 31, 2023 and 2022, respectively.

Derivatives Instruments

In the fourth quarter of 2022, the Company began to use derivative financial instruments to manage foreign currency exchange rate risk. The Company’s derivative financial instruments consist of foreign currency forward contracts, which are used primarily to hedge portions of its anticipated foreign currency exposure. The maturities of these instruments are generally less than twelve months. Fair values for derivative financial instruments are based on prices computed using third-party valuation models and are classified as Level 2 in accordance with the three-level hierarchy of fair value measurements. All the significant inputs to the third-party valuation models are observable in active markets. Inputs include current market-based parameters such as forward rates, yield curves and credit default swap pricing. For additional information related to the three-level hierarchy of fair value measurements, see Note 6 – Fair Value.

The notional and fair values of all derivative instruments were as follows (in thousands):

 

 

March 31, 2023

 

 

December 31, 2022

 

Derivative instruments in cash flow hedges (foreign exchange contracts):

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Other current assets

 

$

769

 

 

$

 

Liabilities

 

 

 

 

 

 

Accrued liabilities

 

 

 

 

 

94

 

Total fair value

 

$

769

 

 

$

94

 

Total notional value

 

$

58,817

 

 

$

52,197

 

Undesignated derivative instruments (foreign exchange contracts):

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Other current assets

 

$

277

 

 

$

 

Liabilities

 

 

 

 

 

 

Accrued liabilities

 

 

 

 

 

41

 

Total fair value

 

$

277

 

 

$

41

 

Total notional value

 

$

9,531

 

 

$

7,402

 

All of the Company's derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparty to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's Condensed Consolidated Balance Sheets on a net basis.

The gross amounts of the Company's foreign currency forward contracts and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets were as follows (in thousands):

 

 

March 31, 2023

 

 

December 31, 2022

 

Gross amount of recognized assets

$

1,078

 

 

$

 

Gross amount of recognized liabilities

 

(32

)

 

 

(135

)

Net amount presented in the Condensed Consolidated Balance Sheets

$

1,046

 

 

$

(135

)

Cash Flow Hedges

The Company designates certain foreign currency forward contracts as hedging instruments pursuant to ASC 815, Derivatives
and Hedging (“ASC 815”). The effective portion of the gain or loss on the derivatives are reported as a component of AOCI in stockholders’ equity and reclassified into earnings on the Condensed Consolidated Statements of Operations in the same period during which the hedged transaction affects earnings. For information on the unrealized gain or loss on the derivatives included in and reclassified out of the AOCI into Condensed Consolidated Statements of Operations, refer to Note 4 –
Composition of Certain Financial Statement Captions.

The Company expects to reclassify to earnings all of the amounts recorded in AOCI associated with its cash flow hedges over the next twelve months. For the three months ended March 31, 2023, amounts reclassified to net loss were not significant. The Company did not enter into any derivative contracts prior to the fourth quarter of 2022.

Undesignated Derivatives

For derivatives that are not designated as hedge instruments, they are measured and reported at fair value. Changes in the fair
value of these undesignated derivatives are reported in other income, net, on the Condensed Consolidated Statements of Operations. For the three months ended March 31, 2023, changes in the estimated fair value of the derivatives were not significant. The Company did not enter any derivative contracts prior to the fourt
h quarter of 2022.